KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $12.82 $19.54 Friday, 26th Apr 2024 MGNX stock ended at $14.56. This is 1.32% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 7.31% from a day low at $14.22 to a day high of $15.26.
90 days $12.82 $21.88
52 weeks $4.29 $21.88

Historical MacroGenics prices

Date Open High Low Close Volume
Apr 12, 2016 $20.73 $20.94 $20.14 $20.81 291 118
Apr 11, 2016 $20.67 $21.60 $19.90 $20.67 240 749
Apr 08, 2016 $20.97 $21.50 $20.10 $20.44 244 983
Apr 07, 2016 $21.13 $21.33 $19.72 $20.32 249 254
Apr 06, 2016 $19.54 $21.48 $19.54 $21.42 342 328
Apr 05, 2016 $19.51 $19.98 $18.98 $19.39 238 634
Apr 04, 2016 $19.14 $20.38 $19.11 $19.84 346 436
Apr 01, 2016 $18.54 $19.13 $18.12 $18.98 279 236
Mar 31, 2016 $17.37 $19.19 $17.37 $18.75 339 305
Mar 30, 2016 $17.37 $18.50 $17.01 $17.64 130 955
Mar 29, 2016 $15.94 $17.23 $15.53 $17.16 195 200
Mar 28, 2016 $16.49 $16.67 $15.67 $15.97 241 400
Mar 24, 2016 $15.80 $16.87 $15.18 $16.38 194 600
Mar 23, 2016 $17.39 $17.59 $15.88 $15.95 272 800
Mar 22, 2016 $16.67 $17.54 $16.67 $17.39 249 300
Mar 21, 2016 $16.08 $17.08 $15.85 $16.78 234 100
Mar 18, 2016 $15.42 $16.24 $15.03 $16.15 444 800
Mar 17, 2016 $15.77 $16.01 $14.90 $15.15 404 400
Mar 16, 2016 $16.04 $16.63 $15.45 $15.89 232 100
Mar 15, 2016 $17.20 $17.20 $16.00 $16.05 351 600
Mar 14, 2016 $17.48 $17.91 $17.06 $17.49 256 800
Mar 11, 2016 $16.72 $17.77 $16.50 $17.60 273 800
Mar 10, 2016 $17.54 $18.09 $16.15 $16.61 317 700
Mar 09, 2016 $17.99 $17.99 $16.71 $17.33 238 200
Mar 08, 2016 $19.37 $19.85 $17.77 $17.87 303 200
Click to get the best stock tips daily for free!

About MacroGenics

MacroGenics MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients with metastatic HER2-positive breast cancer who have received two or more prior anti-HER2 regimens. The... MGNX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT